Risks and Benefits of Magnesium Sulfate Tocolysis in Preterm Labor (PTL)

The U.S. Food and Drug Administration issued a drug safety communication on 05/30/2013 recommending “against prolonged use of magnesium sulfate to stop preterm labor (PTL) due to bone changes in exposed babies.” In September of 2013, The American Congress of Obstetrics and Gynecologists issued Commi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, John P., Morrison, John C., Bofill, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIMS Press 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690360/
https://www.ncbi.nlm.nih.gov/pubmed/29546168
http://dx.doi.org/10.3934/publichealth.2016.2.348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690360/
https://www.ncbi.nlm.nih.gov/pubmed/29546168
http://dx.doi.org/10.3934/publichealth.2016.2.348

Ejemplares similares